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ABSTRACT: Biofilms are surface-attached communities of bacteria
enclosed in a polysaccharide matrix. Bacteria in a biofilm are extremely
resistant to antibiotics. Several recent reports have linked the signaling
molecule nitric oxide (NO) with biofilm dispersal. We have previously
reported that an H-NOX (heme-nitric oxide/oxygen binding) protein in
the biofilm-dwelling bacterium Shewanella woodyi mediates NO-induced
biofilm dispersal. In S. woodyi, H-NOX (SwH-NOX) is cocistronic with a
gene encoding a dual-functioning diguanylate cyclase/phosphodiesterase
enzyme, designated here as HaCE (H-NOX-associated cyclic-di-GMP
processing enzyme). Enzymes such as these are responsible for regulating
the intracellular concentrations of cyclic-di-GMP, a secondary signaling
molecule essential to biofilm formation in bacteria. We have demonstrated
that NO-bound SwH-NOX regulates both enzymatic activities of SwHaCE,
resulting in decreased cellular cyclic-di-GMP levels and disruption of biofilm formation. Thus, H-NOX/HaCE represents a
potential drug target for regulating biofilm formation. In this work, the SwH-NOX surface residues critical for the formation of a
protein complex with SwHaCE are identified using nuclear magnetic resonance, fluorescence quenching, and cosedimentation.
Enzyme assays confirm this protein−protein interface and its importance for H-NOX/HaCE function.
Biofilm formation is an important phenotype in bacteria,where cells switch from a motile, free-swimming, single-
cell growth mode to a surface-attached, sessile, community of
cells encapsulated in a matrix consisting of exopolysaccharide,
protein, and DNA.1,2 Bacteria within biofilms are extremely
resistant to antibiotics and are thought to be responsible for
several drug-resistant infectious diseases. Biofilm development
is poorly understood in general, but the intracellular
concentration of bis-(3′−5′)-cyclic dimeric guanosine mono-
phosphate (cyclic-di-GMP or c-di-GMP) has been shown to be
important for the regulation of motility and biofilm
formation,3,4 in addition to many other important signaling
processes, including cell division, transcriptional regulation, and
virulence.5−8
In bacteria, two classes of enzymes maintain the intracellular
pool of cyclic-di-GMP. Cyclic-di-GMP is synthesized from two
molecules of GTP by GGDEF domain-containing diguanylate
cyclases (DGCs).9−11 Cyclic-di-GMP is hydrolyzed by ExL
domain-containing phosphodiesterases (PDEs)12−14 to form
the linear metabolite 5′-phosphoguanylyl-(3′→5′)-guanosine
(pGpG). Because cyclic-di-GMP signaling and bacterial
biofilms are central to many infectious diseases, the pathways
that contribute to the regulation of intracellular cyclic-di-GMP
concentrations are potentially important antibiotic drug targets.
Nitric oxide (NO) is a well-established and important
signaling molecule in mammals that regulates a variety of
physiological processes, including vasodilation and neuro-
transmission.15 The enzyme soluble guanylate cyclase (sGC)
acts as an NO sensor via its N-terminal heme-nitric oxide/
oxygen binding domain.16 Interestingly, several different groups
have recently observed that low concentrations of NO induce
biofilm dispersal in a variety of bacterial species.17−19 In
bacteria, H-NOX domains typically exist as stand-alone
proteins that regulate cocistronic histidine kinase [H-NOX-
associated histidine kinase (HahK)] or c-di-GMP synthase
and/or phosphodiesterase [H-NOX-associated cyclic-di-GMP
processing enzyme (HaCE)] proteins.20,21 In general, the
biophysical characterization of these H-NOX/enzyme com-
plexes is lacking.
H-NOX signaling in Legionella pneumophila and Shewanella
woodyi, both of which encode a diguanylate cyclase/
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phosphodiesterase protein in the same operon as an H-NOX
domain, has been characterized.22 It is reported that the H-
NOX-associated protein Lpg1057 (LpHaCE) from L. pneumo-
phila has in vitro diguanylate cyclase activity that is inhibited by
NO-bound H-NOX.23 The phosphodiesterase domain was
found to be inactive. In S. woodyi, H-NOX regulates the DGC
and PDE activities of SwHaCE (Swoo_2750), previously
termed SwDGC.24 In the absence of NO, SwH-NOX stimulates
diguanylate cyclase activity while the phosphodiesterase activity
remains at basal levels. In the presence of NO-bound H-NOX,
however, this pattern is reversed. SwHaCE displays basal level
cyclase activity, whereas the phosphodiesterase activity is
upregulated. These results underlie the additional finding that
nanomolar NO leads to less biofilm and a decreased level of
cyclic-di-GMP in S. woodyi. These data are consistent with H-
NOX acting as an NO sensor that regulates biofilm formation
by modulating the intracellular level of cyclic-di-GMP in
bacteria.
Therefore, the H-NOX/HaCE protein−protein interaction is
important for regulating the biofilm formation pathway in some
bacteria. Here we use a combination of techniques to study
how HaCE proteins are regulated by H-NOX. We employ
NMR chemical shift perturbation experiments to identify the
residues of SwH-NOX that interact with SwHaCE. The role of
these residues was confirmed by enzyme activity assays as well
as fluorescence binding studies with mutant proteins.
Sedimentation equilibrium studies were used to assess the
stoichiometry of the SwH-NOX/SwHaCE complex. The data
were used to generate a model for H-NOX regulation of HaCE
activity.
■ EXPERIMENTAL PROCEDURES
Materials and General Methods. All reagents were
obtained at their highest available purity and used as received.
All enzymes were purchased from New England Biolabs.
Protein Expression and Purification. SwH-NOX and
SwHaCE were expressed and purified as described previ-
ously.22,24 In brief, the plasmid containing the SwH-NOX gene
was transformed into Escherichia coli Tuner(DE3)pLysS cells
for protein expression. The cells were grown in yeast extract
medium containing a final sodium phosphate concentration of
100 mM. The protein expression was induced with 10 μM
IPTG (final concentration) at 18 °C overnight. The pellet was
harvested and stored at −80 °C until it was purified. For
purification, the pellet was thawed on ice and resuspended in
H-NOX A buffer [50 mM sodium phosphate and 300 mM
sodium chloride (NaCl) (pH 8.0)]. After sonication, the lysate
was spun at 18000 rpm (39200g) for 1 h. The cleared
supernatant was loaded on a nickel-NTA (GE) column, and the
protein was eluted using an imidazole gradient of H-NOX B
buffer [50 mM sodium phosphate, 300 mM NaCl, and 250 mM
imidazole (pH 8.0)]. The plasmid encoding SwHaCE24 was
transformed into E. coli BL21(DE3)pLysS cells for protein
expression. The cells were grown in 2XYT medium containing
16 g of tryptone, 10 g of yeast extract, and 5 g of NaCl per liter.
Protein expression was induced with 100 μM IPTG (final
concentration) at 16 °C overnight. The pellet was resuspended
in lysis buffer containing 50 mM Tris base, 10 mM magnesium
chloride (MgCl2), 25 mM potassium chloride (KCl), 300 mM
NaCl, 10% glycerol, and 2 mM βME (β-mercaptoethanol) (pH
8.0). Phenylmethanesulfonyl fluoride (PMSF) dissolved in
methanol was added to a final concentration of 1 mM to the
resuspended pellet prior to lysis to inhibit protease activity.
After sonication, the lysate was spun at 18500 rpm (41400g) for
1 h. The cleared supernatant was loaded on a nickel-NTA
column (GE), and the protein was eluted using an imidazole
gradient in lysis buffer. After elution off the Ni column, the
protein was loaded on Superdex-200 (GE) equilibrated in lysis
buffer without glycerol and PMSF to obtain >95% pure protein.
To produce 13C- and 15N-labeled protein, E. coli Tuner-
(DE3)pLysS cells transformed with the SwH-NOX plasmid
were grown in M9 minimal medium supplemented with
15NH4Cl and
13C-labeled glucose (Cambridge Isotope Labo-
ratories, Inc.) as the sole sources of 15N and 13C, respectively.
Protein expression was induced by adding 10 μM IPTG (final
concentration) at 25 °C and allowing cultures to grow
overnight. Then the protein was purified by nickel-NTA
affinity chromatography followed by gel filtration using
Superdex 200. The yield of the isotope-labeled protein was
∼10 mg/L. For all protein-based assays described below, the
protein concentrations were determined using the Bradford
Protein Assay (Thermo Scientific, Pierce).25 The standard
curve for the assay was prepared using BSA (Thermo Scientific,
Pierce).
Site-Directed Mutagenesis. The Stratagene QuikChange
protocol was used to introduce several SwH-NOX point
mutations. The following complementary primers were used to
make the E16K, F17A, and E20K SwH-NOX mutants: E16K,
5′-GGAG TTG ATT GAA GAT AAA TTC GGA TAT GAA
ACC-3′; F17A, 5′-GAG TTG ATT GAA GAT GAG GCT
GGA TAT GAA ACC-3′; and E20K, 5′-GAG TTC GGA TAT
AAA ACC TTA GAT ACT TTA CTT G-3′ (the underlined
portions are the mutated codons). Phusion polymerase was
purchased from New England Biolabs. The mutagenesis
products were transformed into E. coli Dh5α cells for
propagation. The mutations were confirmed using DNA
sequencing results obtained from the DNA sequencing facility
at Stony Brook University. The expression and purification of
SwH-NOX surface mutants were conducted using the same
protocols as described above for the wild-type SwH-NOX
protein.
NMR and Data Analysis. The SwH-NOX Fe(II)−CO
complex was used in the NMR studies to avoid paramagnetic
effects resulting from the unpaired electron in the Fe(II)−NO
and Fe(II)−unligated SwH-NOX complexes. The Fe(II)−CO
complex was prepared in an anaerobic glovebag as previously
described.26 The SwH-NOX concentration was 400 μM,
dissolved in 50 mM sodium phosphate, 50 mM NaCl, and 10
mM sodium dithionite (pH 7.6). Triple-resonance NMR
experiments for the backbone assignments of SwH-NOX
(HNCO, HNCACB, CBCACONH, and HNCA) were
performed at 25 °C on a Bruker 900 MHz spectrometer
equipped with a cryoprobe at the New York Structural Biology
Center (New York, NY). Data were processed using
NMRPipe27 followed by analysis using Sparky;28 75% of the
backbone resonances were assigned.
Transverse relaxation-optimized spectroscopy (TROSY)-
edited 15N−1H HSQC experiments were performed on the
same spectrometer at 25 °C for the following samples: (1) the
15N-labeled Fe(II)−CO SwH-NOX complex and (2) the 15N-
labeled Fe(II)−CO SwH-NOX complex and the nonisotopi-
cally labeled binding partner SwHaCE, at a ratio of 1:1.25. The
buffer used was the same as that used in the three-dimensional
(3D) NMR experiments. Then, the weighted average chemical
shift difference (Δ in parts per million) was calculated using the
equation
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δΔ = Δ + ΔH N{[( ) ( /5) ]/2}2 2 1/2 (1)
Tryptophan Fluorescence Quenching. Intrinsic fluo-
rescence experiments were conducted on a PTI spectrofluor-
ometer. SwHaCE (1 μM) was placed in a cuvette, and the SwH-
NOX Fe(II)−NO complex (WT and mutants E16K, F17A, and
E20K, separately) was titrated serially into the protein while
being stirred constantly at 25 °C. SwHaCE was diluted to 10%
of the starting volume (2000 μL) . Titration was continued
until the maximal change in fluorescence had been achieved.
The data were fit to a first-order binding equation in Origin:
= + + −
= + + −
P x K Px y
A P x K P
temp ( ) 4 ;
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d
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(2)
Sedimentation Velocity and Sedimentation Equili-
brium. Experiments were conducted at 4 °C on a Beckman
Optima XL-Analytical ultracentrifuge using an An-60 Ti rotor.
For sedimentation velocity experiments, SwHaCE was
incubated with the SwH-NOX Fe(II)−NO complex (WT and
mutant E16K, separately), and the protein complex was
centrifuged at 50000 rpm (201240g) for 24 h with 60 scans
at 280 nm. The protein concentration was adjusted so that the
absorbance was 0.8 at 280 nm. The data were analyzed using
SEDFIT.29 The buffer consisted of 50 mM Tris-HCl, 250 mM
NaCl, 25 mM KCl, 10 mM MgCl2, and 2 mM βME (pH 8.0).
For the equilibrium experiments with SwHaCE alone,
SwHaCE was analyzed at three rotor speeds (9000, 14000,
and 18000 rpm, which are equal to 6500g, 15800g, and 26100g,
respectively), which were calculated using the molecular mass
of SwHaCE (74.5 kDa). Two scans were collected at the end of
each speed. The protein absorbance was followed at 280 and
260 nm. The data were analyzed using HeteroAnalysis
(University of Connecticut Analytical Ultracentrifugation
Facility) to determine the molecular mass for SwHaCE alone
in solution. The data were fit globally across samples and
speeds to yield the apparent molar mass.
For the equilibrium experiments with the SwH-NOX/
SwHaCE complex, SwHaCE, either the WT or the E16K
mutant, was incubated with WT SwH-NOX, as either the
Fe(II)-unligated or SwH-NOX Fe(II)−NO complex, in 1:1,
1:2, and 1:5 molar ratios, and analyzed at three rotor speeds
(9000, 14000, and 18000 rpm, which are equal to 6500g,
15800g, and 26100g, respectively) with two scans at the end of
each speed. The scans were collected at an absorbance of 400
nm for experiments with the Fe(II)−NO complex or 430 nm
for experiments with the Fe(II)-unligated complex to follow the
heme absorbance of SwH-NOX. The protein concentration was
adjusted so that the absorbance was 0.5 at 430 nm. For the
equilibrium experiments with SwH-NOX alone, SwH-NOX was
analyzed at three rotor speeds (17000, 27000, and 34000 rpm,
which are equal to 23300g, 58700g, and 93000g, respectively),
which were calculated using the molecular mass of SwH-NOX
(22.5 kDa).
Enzyme Activity Measurements Using the Malachite
Green Assay. The SensoLyte MG phosphate assay kit was
purchased from AnaSpec. For the diguanylate cyclase enzyme
assays, SwHaCE by itself (1 μM), or in the presence of the
SwH-NOX Fe(II)-unligated complex (WT, E16K, F17A, or
E20K in a 1:20 concentration ratio), was incubated on ice for
10 min to allow the proteins to form a complex. The protein
mixtures (20 μL) were then added to 180 μL a prepared
solution containing 200 μM GTP (substrate), 5 mM MgCl2,
and 1× buffer [50 mM Tris base and 10 mM MgCl2 (pH 7.5)].
The reaction mixture was incubated for 10 min at 25 °C
followed by boiling at 100 °C to quench the reaction. After
being cooled, the mixture was spun at 14000 rpm (16900g) for
5 min to remove any precipitate; 70 μL of the supernatant was
mixed with 10 μL of 3 units/mL IPP [inorganic pyrophospha-
tase (NEB)] in a 96-well plate and incubated at 25 °C for 10
min to hydrolyze the inorganic pyrophosphate (PPi) produced
during the reaction. Then, 20 μL of Malachite green reagent
was added and the solution mixed, and the plate was read at
610 nm using a Perkin-Elmer Viktor X5 microplate reader. The
absorbance readings were corrected for protein only and GTP
only background. This experiment measured the initial velocity
for the diguanylate cyclase activity for SwHaCE and SwHaCE in
complex with SwH-NOX. This experiment was repeated in at
least three fully independent experiments.
NO Dissociation Kinetics. NO dissociation kinetics of
SwH-NOX mutants E16K, F17A, and E20K were conducted as
previously described.30
■ RESULTS
Despite the importance of biofilms in infectious diseases, the
mechanisms that regulate biofilm formation and dispersal are
poorly understood. In this study, we have characterized the H-
NOX/HaCE protein complex from S. woodyi to improve our
understanding of how NO causes biofilm dispersal in this
bacterium.
Chemical Shift Perturbation Assays Reveal the Bind-
ing Interface for SwHaCE. We collected HNCO, HNCACB,
CBCACONH, and HNCA spectra to assign the backbone
resonances of SwH-NOX. Using standard methods, resonances
from 75% of the SwH-NOX residues (∼140 residues) could be
assigned, and these assignments were used to probe the binding
of SwHaCE (Figure 1). HSQC NMR spectra of the 15N-labeled
SwH-NOX Fe(II)−CO complex were compared to the spectra
of the 1:1.25 complex of the 15N-labeled SwH-NOX Fe(II)−
CO complex in the presence of SwHaCE. In the presence of
SwHaCE, there was a significant loss of signal in the SwH-NOX
HSQC spectrum because of peak broadening, presumably
Figure 1. Backbone assignment for SwH-NOX [as the Fe(II)−CO
complex]. Approximately 75% of the peaks were assigned using
extensive 3D experiments. The x-axis represents the chemical shift in
1H, and the y-axis represents the chemical shift in 15N.
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because the total size of the SwH-NOX/SwHaCE complex is
expected to be at least 100 kDa (74.5 kDa for SwHaCE and
22.5 kDa for SwH-NOX). Hence, TROSY spectra were
recorded for SwH-NOX alone (Figure 2, red) and in complex
with SwHaCE (Figure 2, blue). No line broadening effects were
observed, and the TROSY spectrum for the complex showed
only one set of peaks, indicating fast exchange on the NMR
time scale.
The chemical shifts of some residues shifted significantly for
the protein/protein complex (Figure 2, blue), compared to the
spectrum of SwH-NOX alone (Figure 2, red). To correlate the
changes in chemical shift with structure, a homology model of
SwH-NOX was generated (Figure 3A). The change in chemical
shift for each assigned residue of SwH-NOX (with and without
SwHaCE) was plotted (Figure 3B). Assuming a ratio of 0.02 to
be a significant change, there are ∼11 SwH-NOX residues that
shift upon exposure to SwHaCE.
We were particularly interested in a set of five residues
(amino acids 16−20) in the N-terminal helices of SwH-NOX
that displayed the maximal shift. These residues form a cluster
in N-terminal helices αB and αC on the surface of SwH-NOX,
suggesting this contributes to the binding site for SwHaCE. To
test this hypothesis, we constructed three SwH-NOX point
mutants (highlighted in Figure 4), E16K, E20K, and F17A. We
reasoned that charge reversal mutants (E16K and E20K) would
be expected to significantly perturb binding if these residues
play a key role and that reducing the bulk of F17 might weaken
hydrophobic interactions during binding.
Characterization of ligand binding (binding of CO and NO
to ferrous SwH-NOX and binding of CN− to ferric SwH-NOX)
and NO dissociation kinetics were conducted for the WT and
the surface mutants of SwH-NOX. The Soret values and
koff(NO) calculated for H-NOX surface mutants were similar to
those of WT H-NOX (Table S1 of the Supporting
Information), confirming that mutating these surface residues
does not affect the overall structure or heme properties of the
SwH-NOX protein.
Fluorescence Quenching Assays Indicate That Bind-
ing of SwHaCE Is Significantly Weaker for Surface
Mutants E16K, F17A, and E20K Than for WT SwH-NOX.
SwHaCE has seven Trp residues, while SwH-NOX has none;
thus, we reasoned that binding of SwH-NOX to SwHaCE might
perturb the Trp fluorescence intensity of SwHaCE. Therefore,
the steady-state fluorescence of 1 μM SwHaCE was followed at
370 nm in the presence of increasing concentrations of NO-
bound H-NOX to assess SwH-NOX/SwHaCE binding. The
SwH-NOX Fe(II)−NO complex (WT or mutant, separately;
∼1−10 μM) was titrated into the SwHaCE solution while it
was being stirred constantly until the maximal change in
fluorescence had been achieved. We observed a quenching of
the fluorescence signal as a function of an increasing
Figure 2. Chemical shift mapping for SwHaCE and SwH-NOX
complex formation. The 15N−1H HSQC spectrum (red) was recorded
for a sample containing uniformly 15N-labeled 50 μM SwH-NOX [as
the Fe(II)−CO complex]. The blue spectrum was recorded for a
1:1.25 ratio of 15N-labeled SwH-NOX [as the Fe(II)−CO complex] to
unlabeled SwHaCE. An overlay of these spectra indicates that peaks for
some residues are shifted, indicating a change in their chemical
environment in the presence of SwHaCE.
Figure 3. (A) Ribbon structure of the SwH-NOX protein from S.
woodyi. This figure is a homology model generated in PyMOL using
the solution-state NMR structure of Shewanella oneidensis26 (So2144,
Protein Data Bank entry 2KII, chain A). The heme is shown as red
sticks. The N- and C-termini of the protein are denoted. The seven
different helices are depicted in different colors: blue for helix αA, red
for helix αB, hot pink for helix αC, orange for helix αD, gray for helix
αE, purple for helix αF, and chocolate brown for helix αG. (B)
Chemical shift changes for SwH-NOX upon addition of SwHaCE. The
shifts (SwH-NOX to SwH-NOX/SwHaCE), calculated as {[(ΔN/5)2
+ (ΔH)2]/2}1/2, are plotted against the primary sequence residue
number. The cutoff shift was kept at 0.02, and shifts above 0.02
(dashed line) were considered significant. The secondary structure of
SwH-NOX is shown as a cartoon in which the rectangles represent α-
helices and the solid arrows represent β-strands. The color code
corresponds to the ribbon diagram in panel A.
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concentration of the SwH-NOX Fe(II)−NO complex in
solution (Figure 5). Here, to have positive numbers, the
difference (F0 − F) is plotted as a function of the concentration
of NO-bound H-NOX in solution for each SwH-NOX
construct. The data were corrected for dilution and inner filter
effects and plotted against SwH-NOX Fe(II)−NO complex
concentration. The apparent dissociation constant (KD,app) for
the complex was determined to be 2.5−3 μM from three
independent runs. This likely overestimates the true KD, as the
concentrations used were high and not under pseudo-first-order
conditions, to account for the sensitivity of the detector.
Nonetheless, the effect of SwH-NOX surface mutations on
binding to SwHaCE could be easily determined in this assay.
For the titrations with the Fe(II)−NO complex of the E16K
mutant of SwH-NOX, the fluorescence signal for SwHaCE did
not decrease over time and actually increased slightly (Figure
5). This indicates that the E16K mutation abolished binding of
SwH-NOX to SwHaCE. The slight increase in the magnitude of
the fluorescence signal toward the end of the titration could be
due to conformational changes resulting from interactions of
the SwH-NOX E16K mutant with other regions of SwHaCE at
high H-NOX concentrations. For the SwH-NOX F17A and
E20K mutants, we observed significantly less quenching of the
SwHaCE signal than for the WT, suggesting a reduced binding
affinity for each of these mutants for SwHaCE (Figure 5).
These results confirm that surface residues E16, F17, and E20
in N-terminal helices αB and αC of SwH-NOX each contribute
to SwHaCE binding and likely are part of a binding surface for
interaction with SwHaCE.
Sedimentation Equilibrium Indicates That SwHaCE
Forms a Dimer in Solution and the SwH-NOX/SwHaCE
Complex Forms a Heterotetramer. On the basis of the
NMR and fluorescence titration experiments described above,
we concluded that SwH-NOX and SwHaCE form a protein/
protein complex. We used sedimentation equilibrium measure-
ments to determine the stoichiometry of this complex.
Sedimentation equilibrium experiments are extensively used
to determine the molecular masses of proteins and protein
complexes in solution.31 On the basis of previously
characterized diguanylate cyclases, it is expected that active
diguanylate cyclases exist as dimers in solution.32−34 Because
SwHaCE is an active cyclase enzyme,24 we wanted to determine
if SwHaCE also forms oligomers (dimers) in solution, and we
wanted to determine if the oligomerization state changes upon
formation of a complex with SwH-NOX.
Sedimentation equilibrium experiments were conducted with
SwHaCE alone, SwH-NOX [as the Fe(II)−NO or Fe(II)-
unligated complex, separately] alone, and a mixture of SwHaCE
and SwH-NOX [as the Fe(II)−NO or Fe(II)-unligated
complex, separately] at a ratio of 1:1.5. These data are
summarized in Table 1. For SwHaCE, HeteroAnalysis indicates
a molecular mass of 144.3 kDa, which is close to the theoretical
molecular mass expected for a dimer, 149 kDa (Figure 6A and
Table 1). For WT SwH-NOX, as either the Fe(II)-unligated or
Figure 4. SwH-NOX surface residues identified from chemical shift mapping. The SwH-NOX residues with the maximal perturbation (E16, F17, and
E20) upon incubation with SwHaCE are colored red. The heme cofactor is also colored red. These residues likely represent the binding patch for
SwHaCE.
Figure 5. Tryptophan fluorescence quenching experiments for
assessing SwH-NOX/SwHaCE binding. The Fe(II)−NO complex of
SwH-NOX [WT (blue diamonds), E16K (red squares), F17A (green
triangles), and E20K (yellow circles)] was titrated into a SwHaCE
solution (1 μM) to determine the amount of SwHaCE Trp quenching.
The difference in fluorescence (F0 − F) with and without SwH-NOX is
plotted as a function of SwH-NOX Fe(II)−NO complex concen-
tration. WT SwH-NOX caused significant quenching of SwHaCE
fluorescence. In general, the SwH-NOX mutants do not quench
SwHaCE fluorescence, indicating a loss of binding. From these data,
the apparent equilibrium dissociation constant for the SwH-NOX/
SwHaCE complex was determined to be ∼2.5 μM (the gray line shows
the fit used to determine KD,app). Each titration was conducted in
triplicate.
Biochemistry Article
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Fe(II)−NO complex, our analysis indicated a molecular mass
of 23 kDa, which is close to the theoretical molecular mass of
22.5 kDa (Figure S1 of the Supporting Information and Table
1). Thus, WT SwH-NOX alone exists as a monomer and
SwHaCE as a dimer.
The molecular mass for the SwH-NOX/SwHaCE complex,
which was monitored at 400 nm (to follow heme absorbance),
was calculated to be 197.2 kDa when SwH-NOX was run as the
Fe(II)−NO complex (Figure 6B and Table 1) and 198.0 kDa
when SwH-NOX was run as the Fe(II)-unligated complex
(monitored at 430 nm to follow heme absorbance) (Figure S2
of the Supporting Information and Table 1), both of which are
close to the theoretical molecular mass of 193 kDa for a
heterotetrameric complex of four molecules comprised of two
SwHaCE monomers and two SwH-NOX monomers. All of the
molecular masses computed from the AUC experiments are
within 3% of the theoretical value, which is within the
experimental error of the instrument. Therefore, we conclude
that SwHaCE and SwH-NOX form a 2:2 heterotetrameric
protein complex in solution, regardless of whether NO is bound
to SwH-NOX. Because SwH-NOX and SwHaCE are cocis-
tronic, these data support our model in which H-NOX and
HaCE likely form a complex upon production in bacterial
cells.24 This is the first H-NOX/HaCE protein complex
stoichiometry to have been determined.
The E16K SwH-NOX mutant [as the Fe(II)−NO complex]
was analyzed both by itself and as a complex with SwHaCE.
The mutant was determined to be a monomer by itself
[calculated molecular mass of 23 kDa (Figure S1 of the
Supporting Information and Table 1)], similar to WT SwH-
NOX. The E16K SwH-NOX/SwHaCE protein mixture,
followed at the heme absorbance, did not form a complex, as
suggested by the calculated molecular mass of 76.5 kDa (Figure
S2 of the Supporting Information and Table 1). In support of
this, when SwH-NOX was run without SwHaCE at the optimal
rotor speeds to analyze the 193 kDa SwH-NOX/SwHaCE
complex, rather than the 22.5 kDa SwH-NOX species alone, we
obtained a calculated molecular mass of 75 kDa (Figure S2 of
the Supporting Information and Table 1). The molecular mass
of SwH-NOX is not accurately calculated at the rotor speeds
used to analyze the SwH-NOX/SwHaCE complex because
higher angular velocities are required for lower-molecular mass
solutes to balance the sedimentation and diffusion forces within
the radius of the centrifuge cell. This result again suggests a loss
of SwH-NOX/SwHaCE binding due to this SwH-NOX surface
mutation.
Enzyme Assays Confirm the SwH-NOX/SwHaCE Bind-
ing Interface. Next we tested the effect of SwH-NOX and
SwH-NOX surface mutants on the regulation of SwHaCE
activity. We have previously reported that the diguanylate
cyclase activity for SwHaCE increases in the presence of the
WT SwH-NOX Fe(II)-unligated complex, whereas the
phosphodiesterase activity is enhanced in the presence of the
WT SwH-NOX Fe(II)−NO complex.24 In these studies, we
used a new reaction end point assay for cyclase activity, based
on the detection of phosphate (Pi) in solution with the dye
Malachite green.
In a diguanylate cyclase-catalyzed reaction, two molecules of
GTP are condensed to generate PPi (inorganic pyrophosphate)
as a byproduct along with cyclic-di-GMP (2GTP → cyclic-di-
Table 1. Summary of Sedimentation Equilibrium Results and
Controls
protein/protein complex
calculated molecular mass
(theoretical molecular mass)
(kDa)f
HaCE by itselfa,b 144.3 (149.0, dimer)
HaCE with WT H-NOX Fe(II)−NOa,c 197.2 (193.0, 2+2
heterotetramer)
HaCE with WT H-NOX Fe(II)a,d 198.0 (193.0, 2+2
heterotetramer)
HaCE with E16K H-NOX Fe(II)−NOa,c 76.0 (−)
WT H-NOX Fe(II)−NOa,c 75.0 (−)
WT H-NOX Fe(II)−NOe,c 23.3 (22.5, monomer)
WT H-NOX Fe(II)e,d 23.0 (22.5, monomer)
E16K H-NOX Fe(II)−NOe,c 23.8 (22.5, monomer)
aThe sedimentation equilibrium run was conducted at three rotor
speeds calculated for the molecular mass of SwHaCE (74.5 kDa): 9000
rpm (6520g), 14000 rpm (15800g), and 18000 rpm (26100g). bThe
scans for the sedimentation equilibrium runs were collected at 280 nm.
cThe scans for the sedimentation equilibrium runs were collected at
400 nm. dThe scans for the sedimentation equilibrium runs were
collected at 430 nm. eThe sedimentation equilibrium run was
conducted at three rotor speeds calculated for the molecular mass of
SwH-NOX (22.5 kDa): 17000 rpm (23300g), 27000 rpm (58700g),
and 34000 rpm (93100g). fHeteroAnalysis and Sednterp were used to
calculate the molecular mass.
Figure 6. (A) Sedimentation equilibrium experiments with SwHaCE
in solution. Using rotor speeds of 9000, 14000, and 18000 rpm (which
are equal to 6500g, 15800g, and 26100g, respectively), and following
protein at 280 nm, the calculated molecular mass of SwHaCE is 144.3
kDa, indicating a dimer in solution at equilibrium. (B) Sedimentation
equilibrium experiment for SwHaCE in solution with the SwH-NOX
Fe(II)−NO complex. Using rotor speeds of 9000, 14000, and 18000
rpm (which are equal to 6500g, 15800g, and 26100g, respectively), and
following protein complexes at 400 nm, the calculated molecular mass
for the complex is 197.2 kDa at equilibrium. This matches the
molecular mass expected for a heterotetramer of two SwH-NOX
proteins and two SwHaCE proteins. Each experiment was conducted
in triplicate.
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GMP + 2PPi).
35 In the presence of the enzyme inorganic
pyrophosphatase (IPP), PPi is hydrolyzed to Pi (inorganic
phosphate) in solution (2PPi → 2Pi).
36 Malachite green is a
commercially available reagent, which is used to determine the
concentration of free Pi in solution.
37 This end point assay can
be used to quantify diguanylate cyclase activity by measuring
the amount of Pi generated from PPi produced during the
reaction. Because this is an end point assay, the SwHaCE
enzyme was boiled before IPP was added to the solution to
ensure that IPP does not interfere with the activity of the
enzyme. To confirm that IPP is not the rate-limiting enzyme in
the reaction, the concentration of IPP was doubled to confirm
that the same amount of Pi was generated (Table S2 of the
Supporting Information). Because we are detecting the amount
of PPi produced in the reaction, the turnover of cyclic-di-GMP
into pGpG by the phosphodiesterase domain of SwHaCE does
not affect the measurement. As a control, the amount of Pi
generated was determined at various concentrations of
SwHaCE (Figure S3 of the Supporting Information). A linear
correlation was observed between the enzyme concentration
and the amount of Pi produced, confirming that only SwHaCE
is the rate-limiting enzyme in the reaction.
This assay was used to determine the concentration of Pi
generated during the reaction of SwHaCE with GTP in the
presence of the WT, E16K, F17A, and E20K SwH-NOX Fe(II)-
unligated complexes. The specific activity values are reported in
Figure 7 as concentrations of Pi (micromolar per minute per
milligram). It was observed that the WT SwH-NOX Fe(II)-
unligated complex (20 μM) increased the initial velocity of the
cyclase activity of SwHaCE (1 μM) by 2-fold in the presence of
200 μM GTP, as expected from our previous work24 (Figure
7). In general, addition of the SwH-NOX mutants led to a loss
of this enhanced effect, indicating a loss of SwH-NOX binding
and regulation of SwHaCE cyclase activity. For the E16K and
E20K SwH-NOX mutants, the observed initial velocity was
lower than that of SwHaCE with WT SwH-NOX but slightly
higher than that of the enzyme by itself, indicating some
residual binding and regulation by SwH-NOX, but significantly
less than that observed with WT SwH-NOX. For F17A SwH-
NOX, we observed the same initial velocity as SwHaCE without
SwH-NOX. These data, like all of the experiments described
above, also indicate that SwH-NOX/SwHaCE binding has been
disrupted by the surface mutations and support our conclusion
that SwH-NOX binds to SwHaCE, at least in part, using the N-
terminal helical region of H-NOX.
■ DISCUSSION
The spatiotemporal regulation of intracellular cyclic-di-GMP is
central to many important cellular processes like virulence,
biofilm formation, quorum sensing, motility, and cell
division.38,39 Diguanylate cyclase and phosphodiesterase
enzymes, which maintain the intracellular pool of cyclic-di-
GMP, are usually found to be associated with regulatory
domains and/or proteins that modulate their activity. However,
very few of these enzymes have been characterized with their
regulatory partner protein.
NO has been shown to play an important role in bacterial
signaling, and recent studies have indicated that low
concentrations of NO disperse biofilms in bacteria through
the regulation of cyclic-di-GMP concentrations.40 We have
previously reported that NO disperses biofilms in the marine,
bioluminescent, biofilm-dwelling bacterium S. woodyi through
H-NOX by regulating the production of cyclic-di-GMP by
HaCE.24 It was shown that SwH-NOX and NO differentially
modulate the enzymatic activities of both the diguanylate
cyclase and phosphodiesterase domains of SwHaCE. These
results necessitate a model in which H-NOX and HaCE are
associated in a manner that is independent of the ligation state
of H-NOX. Data presented in this study confirm that SwH-
NOX and SwHaCE form a complex independent of the ligation
state of H-NOX.
This study investigates the structural and biophysical details
of the association between SwH-NOX and SwHaCE. We have
used NMR chemical shift perturbation analysis along with peak
assignments for SwH-NOX to identify the critical H-NOX
surface residues that are involved in binding to SwHaCE. The
tremendous change in the chemical environment of a patch of
N-terminal residues, including residues E16, F17, and E20,
indicates a binding region for SwHaCE on SwH-NOX (Figure
3A,B). We also identified other residues (approximately six or
seven) with significant chemical shift perturbations upon
binding to SwHaCE that are spread out on other parts of
SwH-NOX. These chemical shift perturbations may indicate
additional binding surface area or, alternatively, a conforma-
tional rearrangement of SwH-NOX that is triggered upon
binding to SwHaCE.
To determine the role of identified SwH-NOX N-terminal
amino acids (E16, F17, and E20) in binding SwHaCE, we made
mutants of each and investigated the effect of mutation in
several binding and enzymatic assays. Fluorescence binding
assays indicate a significant loss of binding (Figure 5) and
alteration of enzyme regulation (Figure 7) for individual
mutants of these surface residues (E16, F17, and E20). Hence,
we can conclude that these residues mediate interaction of
SwH-NOX with SwHaCE. Sedimentation equilibrium experi-
ments reveal the WT SwH-NOX/SwHaCE protein complex to
be a heterotetramer (Figure 6B), in both the Fe(II)-unligated
and Fe(II)−NO-bound states, whereas SwH-NOX alone and all
the surface mutants in the presence of SwHaCE were
determined to be monomeric in solution.
Figure 7. Regulation of SwHaCE diguanylate cyclase activity by SwH-
NOX. Addition of 20 μM Fe(II)-unligated complex of SwH-NOX to
SwHaCE causes a significant increase in the specific activity of
SwHaCE. Addition of any of the Fe(II)-unligated SwH-NOX surface
mutants (E16K, F17A, and E20K, all at 20 μM), however, had a
weaker effect or no effect on SwHaCE activity, indicating weakened
binding to SwHaCE. All assays contained 1 μM SwHaCE and 200 μM
GTP as substrate. Error bars represent three independent trials on
different days. A Student’s p test was conducted to determine
significance. Asterisks indicate p ≤ 0.006. Each data set was compared
to the activity of SwHaCE with WT SwH-NOX Fe(II).
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On the basis of our results, we developed a model for the
SwH-NOX/SwHaCE protein complex. Because SwH-NOX and
SwHaCE are cocistronic,24 we hypothesize that they are
expressed together in the cell and always associate to form
this heterotetrameric complex. This association likely occurs via
dimerization of SwHaCE, followed by binding of two molecules
of SwH-NOX to the SwHaCE dimer, as illustrated in Figure 8.
Upon expression, presumably, SwH-NOX is in the Fe(II)-
unligated state, and hence, the cyclase activity of SwHaCE is
enhanced to generate more cyclic-di-GMP. When the signal
(NO) binds, there must be a change in the conformation of the
heterotetrameric protein complex, leading to a change in the
activity of SwHaCE that results in less cyclic-di-GMP produced,
ultimately causing biofilm dispersal. If monomeric SwHaCE
also binds SwH-NOX, there may be a complex equilibrium
involving dimerization of SwHaCE, monomeric association of
the SwH-NOX/SwHaCE complex, and two monomers of SwH-
NOX binding to the SwHaCE dimer to form the final
heterotetrameric species. However, sedimentation equilibrium
cannot be used to determine the ratio of these species in
solution.
Furthermore, the data presented here indicate that N-
terminal helices αA−αC mediate binding to SwHaCE. This
result is supported by several previous studies that also point to
the role of the N-terminal helices in transmitting the signal of
NO binding to H-NOX partner proteins. In crystal structures of
the H-NOX domain from Nostoc punctiforme,41 the N-terminal
helices have been shown to be maximally displaced upon
binding of the signaling ligands NO and CO, suggesting that
movement in helices αA−αC constitutes part of the signal
transfer mechanism. Furthermore, a recent study from the
Marletta lab describes the important higher-order interactions
in sGC, elucidating the mechanism of NO-regulated
stimulation of activity.42 They found that in the N-terminal
region of sGC, H-NOX participates in the signal transfer
mechanism by binding to the PAS domain. Mutational studies
confirm that NO binding triggers these local interactions,
leading to global conformational changes, ultimately increasing
activity.
Further evidence that the N-terminal helices of H-NOX are
important for interaction with partner proteins and signal
propagation comes from studies of the structure of the heme
cofactor of H-NOX. The heme unit in H-NOX is highly
distorted from planarity,43 but structural studies have indicated
that mutation of a conserved proline residue in the proximal
heme pocket causes substantial heme flattening.44 The
conformational change caused by heme flattening propagates
to the surface of H-NOX, causing a shift in the position of the
N-terminal helices. We have shown in SwH-NOX that the
heme-flattened mutant affects SwHaCE activity exactly the
same as binding of NO to WT SwH-NOX,45 indicating heme
flattening causes a structural change similar to that of binding of
the SwH-NOX/SwHaCE complex to NO. These data suggest
that transmission of the NO signal involves the N-terminal
helices, which is highly supportive of our results reported here,
indicating the N-terminal helices are involved in binding HaCE,
which is required for translation of NO binding to the
enzymatic active sites.
Taken together, there is strong evidence that ligand binding
events in bacterial H-NOX domains cause conformational
changes that are relayed to the N-terminal helices, which serve
as a binding site for interaction with partner enzymes such as
HaCEs or HahKs (H-NOX-associated histidine kinases),
ultimately resulting in functional changes within the cell.
In conclusion, NO and cyclic-di-GMP are becoming
increasingly important as signaling molecules that direct
bacteria on how to make the choice between motile and
sessile lifestyles. This study is the first of its kind that provides a
structural understanding of how a bacterial NO-sensing protein,
H-NOX, can regulate its associated enzyme activity (HaCE and
HahK), to control the downstream functions such as biofilm
formation. Such studies improve our understanding of how
small molecule signaling regulates downstream functions and
how enzymes that regulate the cyclic-di-GMP concentration in
the cell are functionally regulated by a signal-sensing protein.
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